BIOVENTUS INC - A (BVS) Stock Fundamental Analysis
NASDAQ:BVS - Nasdaq - US09075A1088 - Common Stock - Currency: USD
Taking everything into account, BVS scores 4 out of 10 in our fundamental rating. BVS was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While BVS is still in line with the averages on profitability rating, there are concerns on its financial health. BVS scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year BVS was profitable.
BVS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: BVS reported negative net income in multiple years.
Of the past 5 years BVS 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of BVS (-4.57%) is better than 66.31% of its industry peers.
BVS has a Return On Equity (-21.34%) which is comparable to the rest of the industry.
BVS's Return On Invested Capital of 3.71% is fine compared to the rest of the industry. BVS outperforms 72.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.57% | ||
| ROE | -21.34% | ||
| ROIC | 3.71% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 4.27%, BVS is in the better half of the industry, outperforming 68.98% of the companies in the same industry.
In the last couple of years the Operating Margin of BVS has declined.
The Gross Margin of BVS (67.45%) is better than 73.80% of its industry peers.
BVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.27% | ||
| PM (TTM) | N/A | ||
| GM | 67.45% |
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
2. Health
2.1 Basic Checks
BVS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for BVS has been increased compared to 1 year ago.
Compared to 5 years ago, BVS has more shares outstanding
Compared to 1 year ago, BVS has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.97, we must say that BVS is in the distress zone and has some risk of bankruptcy.
BVS has a Altman-Z score of 0.97. This is comparable to the rest of the industry: BVS outperforms 51.34% of its industry peers.
The Debt to FCF ratio of BVS is 14.89, which is on the high side as it means it would take BVS, 14.89 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BVS (14.89) is better than 72.19% of its industry peers.
A Debt/Equity ratio of 2.15 is on the high side and indicates that BVS has dependencies on debt financing.
BVS has a worse Debt to Equity ratio (2.15) than 86.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.15 | ||
| Debt/FCF | 14.89 | ||
| Altman-Z | 0.97 |
ROIC/WACC0.43
WACC8.58%
2.3 Liquidity
BVS has a Current Ratio of 1.43. This is a normal value and indicates that BVS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.43, BVS is doing worse than 77.54% of the companies in the same industry.
A Quick Ratio of 0.89 indicates that BVS may have some problems paying its short term obligations.
BVS has a worse Quick ratio (0.89) than 82.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 31.58% over the past year.
The earnings per share for BVS have been decreasing by -16.93% on average. This is quite bad
BVS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.89%.
The Revenue has been growing by 11.01% on average over the past years. This is quite good.
EPS 1Y (TTM)31.58%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%10.53%
Revenue 1Y (TTM)11.89%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-2.35%
3.2 Future
The Earnings Per Share is expected to grow by 19.79% on average over the next years. This is quite good.
BVS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.02% yearly.
EPS Next Y51.86%
EPS Next 2Y38.04%
EPS Next 3Y19.79%
EPS Next 5YN/A
Revenue Next Year0.07%
Revenue Next 2Y3.12%
Revenue Next 3Y4.02%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 13.84 indicates a correct valuation of BVS.
Based on the Price/Earnings ratio, BVS is valued cheaper than 87.17% of the companies in the same industry.
BVS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.48.
The Price/Forward Earnings ratio is 7.73, which indicates a rather cheap valuation of BVS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BVS indicates a rather cheap valuation: BVS is cheaper than 95.72% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.04, BVS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.84 | ||
| Fwd PE | 7.73 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BVS is valued cheaper than 85.03% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BVS is valued cheaply inside the industry as 85.03% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.75 | ||
| EV/EBITDA | 12.22 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BVS's earnings are expected to grow with 19.79% in the coming years.
PEG (NY)0.27
PEG (5Y)N/A
EPS Next 2Y38.04%
EPS Next 3Y19.79%
5. Dividend
5.1 Amount
BVS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.92
-0.01 (-0.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners72.05%
Inst Owner Change0.45%
Ins Owners2.56%
Ins Owner Change3.96%
Market Cap568.41M
Analysts77.5
Price Target14.28 (106.36%)
Short Float %2.72%
Short Ratio3.98
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)158.87%
Min EPS beat(2)78.22%
Max EPS beat(2)239.51%
EPS beat(4)4
Avg EPS beat(4)149.48%
Min EPS beat(4)78.22%
Max EPS beat(4)239.51%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.37%
Min Revenue beat(2)-0.04%
Max Revenue beat(2)4.79%
Revenue beat(4)3
Avg Revenue beat(4)4.21%
Min Revenue beat(4)-0.04%
Max Revenue beat(4)8.81%
Revenue beat(8)7
Avg Revenue beat(8)4.85%
Revenue beat(12)9
Avg Revenue beat(12)2.01%
Revenue beat(16)11
Avg Revenue beat(16)2.19%
PT rev (1m)-6.67%
PT rev (3m)-6.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.56%
EPS NY rev (1m)0%
EPS NY rev (3m)7.61%
Revenue NQ rev (1m)-0.29%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.84 | ||
| Fwd PE | 7.73 | ||
| P/S | 1 | ||
| P/FCF | 23.75 | ||
| P/OCF | 22.32 | ||
| P/B | 3.84 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.22 |
EPS(TTM)0.5
EY7.23%
EPS(NY)0.9
Fwd EY12.94%
FCF(TTM)0.29
FCFY4.21%
OCF(TTM)0.31
OCFY4.48%
SpS6.91
BVpS1.8
TBVpS-3.11
PEG (NY)0.27
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.57% | ||
| ROE | -21.34% | ||
| ROCE | 4.69% | ||
| ROIC | 3.71% | ||
| ROICexc | 3.88% | ||
| ROICexgc | 21.12% | ||
| OM | 4.27% | ||
| PM (TTM) | N/A | ||
| GM | 67.45% | ||
| FCFM | 4.21% |
ROA(3y)-11.81%
ROA(5y)-6.59%
ROE(3y)-54.27%
ROE(5y)-31.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y44.62%
ROICexcg growth 5Y-8.7%
ROICexc growth 3Y36.86%
ROICexc growth 5Y-12.41%
OM growth 3Y-2.88%
OM growth 5Y-14.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y-1.56%
F-Score4
Asset Turnover0.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.15 | ||
| Debt/FCF | 14.89 | ||
| Debt/EBITDA | 4.3 | ||
| Cap/Depr | 3.1% | ||
| Cap/Sales | 0.27% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 34.48% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.43 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 0.97 |
F-Score4
WACC8.58%
ROIC/WACC0.43
Cap/Depr(3y)9.96%
Cap/Depr(5y)13.06%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.58%
EPS 3Y-16.93%
EPS 5YN/A
EPS Q2Q%10.53%
EPS Next Y51.86%
EPS Next 2Y38.04%
EPS Next 3Y19.79%
EPS Next 5YN/A
Revenue 1Y (TTM)11.89%
Revenue growth 3Y9.98%
Revenue growth 5Y11.01%
Sales Q2Q%-2.35%
Revenue Next Year0.07%
Revenue Next 2Y3.12%
Revenue Next 3Y4.02%
Revenue Next 5YN/A
EBIT growth 1Y22.32%
EBIT growth 3Y6.82%
EBIT growth 5Y-5.11%
EBIT Next Year17.28%
EBIT Next 3Y13.26%
EBIT Next 5YN/A
FCF growth 1Y3671.34%
FCF growth 3Y34.24%
FCF growth 5Y-0.3%
OCF growth 1Y155.46%
OCF growth 3Y19.05%
OCF growth 5Y-0.96%